{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T18:34:57Z","timestamp":1792521297223,"version":"4.5.0"},"reference-count":102,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,16]],"date-time":"2017-05-16T00:00:00Z","timestamp":1494892800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002999","name":"Dutch Ministry of Health, Welfare and Sport","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002999","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biotechnology Advances"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.biotechadv.2017.05.003","type":"journal-article","created":{"date-parts":[[2017,5,15]],"date-time":"2017-05-15T22:00:37Z","timestamp":1494885637000},"page":"565-574","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":277,"title":["Bioengineering bacterial outer membrane vesicles as vaccine platform"],"prefix":"10.1016","volume":"35","author":[{"given":"Matthias J.H.","family":"Gerritzen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk E.","family":"Martens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9 H.","family":"Wijffels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo","family":"van der Pol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiel","family":"Stork","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"44","key":"10.1016\/j.biotechadv.2017.05.003_bb0005","doi-asserted-by":"crossref","first-page":"24963","DOI":"10.1021\/acsami.5b08811","article-title":"Bacterial nanobioreactors--directing enzyme packaging into bacterial outer membrane vesicles","volume":"7","author":"Alves","year":"2015","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"5\u20136","key":"10.1016\/j.biotechadv.2017.05.003_bb0010","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.vaccine.2003.08.027","article-title":"Stability of mono- and trivalent meningococcal outer membrane vesicle vaccines","volume":"22","author":"Arigita","year":"2004","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.biotechadv.2017.05.003_bb0015","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/nbt1029","article-title":"Recombinant protein folding and misfolding in Escherichia coli","volume":"22","author":"Baneyx","year":"2004","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.biotechadv.2017.05.003_bb0020","series-title":"OMV (Outer Membrane Vesicle) Vaccines","author":"Bartolini","year":"2012"},{"key":"10.1016\/j.biotechadv.2017.05.003_bb0025","doi-asserted-by":"crossref","DOI":"10.3402\/jev.v2i0.20181","article-title":"Recombinant outer membrane vesicles carrying Chlamydia muridarum HtrA induce antibodies that neutralize chlamydial infection in vitro","volume":"2","author":"Bartolini","year":"2013","journal-title":"Journal of extracellular vesicles"},{"issue":"1","key":"10.1016\/j.biotechadv.2017.05.003_bb0030","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jbiotec.2011.11.006","article-title":"A new cloning system based on the OprI lipoprotein for the production of recombinant bacterial cell wall-derived immunogenic formulations","volume":"157","author":"Basto","year":"2012","journal-title":"J. Biotechnol."},{"issue":"6","key":"10.1016\/j.biotechadv.2017.05.003_bb0035","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0966-842X(00)01771-6","article-title":"The structural basis of CEACAM-receptor targeting by neisserial Opa proteins","volume":"8","author":"Billker","year":"2000","journal-title":"Trends Microbiol."},{"issue":"2","key":"10.1016\/j.biotechadv.2017.05.003_bb0040","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.tibtech.2010.11.003","article-title":"Decorating microbes: surface display of proteins on Escherichia coli","volume":"29","author":"van Bloois","year":"2011","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.biotechadv.2017.05.003_bb0045","doi-asserted-by":"crossref","first-page":"19234","DOI":"10.1038\/srep19234","article-title":"Plug-and-display: decoration of virus-like particles via isopeptide bonds for modular immunization","volume":"6","author":"Brune","year":"2016","journal-title":"Sci. Rep."},{"issue":"24","key":"10.1016\/j.biotechadv.2017.05.003_bb0050","doi-asserted-by":"crossref","first-page":"13809","DOI":"10.1073\/pnas.1936124100","article-title":"Cellulosome assembly revealed by the crystal structure of the cohesin-dockerin complex","volume":"100","author":"Carvalho","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7","key":"10.1016\/j.biotechadv.2017.05.003_bb0055","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1073\/pnas.0805532107","article-title":"Delivery of foreign antigens by engineered outer membrane vesicle vaccines","volume":"107","author":"Chen","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"26","key":"10.1016\/j.biotechadv.2017.05.003_bb0060","doi-asserted-by":"crossref","first-page":"E3609","DOI":"10.1073\/pnas.1518311113","article-title":"Outer membrane vesicles displaying engineered glycotopes elicit protective antibodies","volume":"113","author":"Chen","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"10","key":"10.1016\/j.biotechadv.2017.05.003_bb0065","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/0264-410X(96)00020-5","article-title":"Production, characterization and control of a Neisseria meningitidis hexavalent class 1 outer membrane protein containing vesicle vaccine","volume":"14","author":"Claassen","year":"1996","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.biotechadv.2017.05.003_bb0070","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01625-14","article-title":"Human factor H (FH) impairs protective meningococcal anti-FHbp antibody responses and the antibodies enhance FH binding","volume":"5","author":"Costa","year":"2014","journal-title":"MBio"},{"issue":"18","key":"10.1016\/j.biotechadv.2017.05.003_bb0075","doi-asserted-by":"crossref","first-page":"5854","DOI":"10.1128\/AEM.01941-14","article-title":"Decoration of outer membrane vesicles with multiple antigens by using an autotransporter approach","volume":"80","author":"Daleke-Schermerhorn","year":"2014","journal-title":"Appl. Environ. Microbiol."},{"issue":"2","key":"10.1016\/j.biotechadv.2017.05.003_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0148840","article-title":"Impact of reducing complement inhibitor binding on the immunogenicity of native Neisseria meningitidis outer membrane vesicles","volume":"11","author":"Daniels-Treffandier","year":"2016","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.biotechadv.2017.05.003_bb0085","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.vaccine.2009.11.035","article-title":"Intranasal immunization with a proteoliposome-derived cochleate containing recombinant gD protein confers protective immunity against genital herpes in mice","volume":"28","author":"Del Campo","year":"2010","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.biotechadv.2017.05.003_bb0090","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1128\/MMBR.00031-09","article-title":"Virulence and immunomodulatory roles of bacterial outer membrane vesicles","volume":"74","author":"Ellis","year":"2010","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.biotechadv.2017.05.003_bb0095","doi-asserted-by":"crossref","DOI":"10.3402\/jev.v3.24015","article-title":"Antibody-mediated immunity induced by engineered Escherichia coli OMVs carrying heterologous antigens in their lumen","volume":"3","author":"Fantappie","year":"2014","journal-title":"Journal of extracellular vesicles"},{"key":"10.1016\/j.biotechadv.2017.05.003_bb0100","series-title":"Glycoengineered Outer Membrane Vesicles and use Thereof as Vaccines","author":"Feldman","year":"2013"},{"issue":"15","key":"10.1016\/j.biotechadv.2017.05.003_bb0105","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.micinf.2004.08.015","article-title":"Endotoxin recognition and signal transduction by the TLR4\/MD2-complex","volume":"6","author":"Fitzgerald","year":"2004","journal-title":"Microbes Infect."},{"issue":"3","key":"10.1016\/j.biotechadv.2017.05.003_bb0110","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/0022-2836(86)90171-3","article-title":"Cell surface exposure of the outer membrane protein OmpA of Escherichia coli K-12","volume":"188","author":"Freudl","year":"1986","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.biotechadv.2017.05.003_bb0115","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jconrel.2014.11.029","article-title":"Active loading into extracellular vesicles significantly improves the cellular uptake and photodynamic effect of porphyrins","volume":"205","author":"Fuhrmann","year":"2015","journal-title":"J. Control. Release"},{"issue":"Pt 3","key":"10.1016\/j.biotechadv.2017.05.003_bb0120","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1042\/BA20060041","article-title":"Optimization of the conjugation method for a serogroup B\/C meningococcal vaccine","volume":"45","author":"Fukasawa","year":"2006","journal-title":"Biotechnol. Appl. Biochem."},{"issue":"35","key":"10.1016\/j.biotechadv.2017.05.003_bb0125","doi-asserted-by":"crossref","first-page":"4376","DOI":"10.1016\/j.vaccine.2013.12.026","article-title":"The delicate balance in genetically engineering live vaccines","volume":"32","author":"Galen","year":"2014","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.biotechadv.2017.05.003_bb0130","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1021\/nl504798g","article-title":"Modulating antibacterial immunity via bacterial membrane-coated nanoparticles","volume":"15","author":"Gao","year":"2015","journal-title":"Nano Lett."},{"issue":"5","key":"10.1016\/j.biotechadv.2017.05.003_bb0135","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.copbio.2005.07.008","article-title":"Preparative expression of secreted proteins in bacteria: status report and future prospects","volume":"16","author":"Georgiou","year":"2005","journal-title":"Curr. Opin. Biotechnol."},{"issue":"14","key":"10.1016\/j.biotechadv.2017.05.003_bb0140","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.88907","article-title":"Enhanced protective antibody to a mutant meningococcal factor H-binding protein with low-factor H binding","volume":"1","author":"Granoff","year":"2016","journal-title":"JCI Insight"},{"issue":"2","key":"10.1016\/j.biotechadv.2017.05.003_bb0145","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1021\/nn405724x","article-title":"Bioengineered bacterial outer membrane vesicles as cell-specific drug-delivery vehicles for cancer therapy","volume":"8","author":"Gujrati","year":"2014","journal-title":"ACS Nano"},{"issue":"2","key":"10.1016\/j.biotechadv.2017.05.003_bb0150","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1074\/jbc.M110.185744","article-title":"Selective sorting of cargo proteins into bacterial membrane vesicles","volume":"286","author":"Haurat","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biotechadv.2017.05.003_bb0155","doi-asserted-by":"crossref","first-page":"37242","DOI":"10.1038\/srep37242","article-title":"Employing Escherichia coli-derived outer membrane vesicles as an antigen delivery platform elicits protective immunity against Acinetobacter baumannii infection","volume":"6","author":"Huang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biotechadv.2017.05.003_bb0160","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12934-014-0162-8","article-title":"An autotransporter display platform for the development of multivalent recombinant bacterial vector vaccines","volume":"13","author":"Jong","year":"2014","journal-title":"Microb. Cell Factories"},{"issue":"7","key":"10.1016\/j.biotechadv.2017.05.003_bb0165","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.vaccine.2012.12.031","article-title":"Preclinical safety and immunogenicity evaluation of a nonavalent PorA native outer membrane vesicle vaccine against serogroup B meningococcal disease","volume":"31","author":"Kaaijk","year":"2013","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.biotechadv.2017.05.003_bb0170","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1074\/jbc.M307628200","article-title":"Incorporation of heterologous outer membrane and periplasmic proteins into Escherichia coli outer membrane vesicles","volume":"279","author":"Kesty","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.biotechadv.2017.05.003_bb0175","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jmb.2008.03.076","article-title":"Engineered bacterial outer membrane vesicles with enhanced functionality","volume":"380","author":"Kim","year":"2008","journal-title":"J. Mol. Biol."},{"issue":"10","key":"10.1016\/j.biotechadv.2017.05.003_bb0180","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1016\/j.bbamem.2009.08.001","article-title":"Structural modifications of outer membrane vesicles to refine them as vaccine delivery vehicles","volume":"1788","author":"Kim","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"issue":"8","key":"10.1016\/j.biotechadv.2017.05.003_bb0185","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.4049\/jimmunol.1200742","article-title":"Immunization with Escherichia coli outer membrane vesicles protects bacteria-induced lethality via Th1 and Th17 cell responses","volume":"190","author":"Kim","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.biotechadv.2017.05.003_bb0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.micres.2014.09.006","article-title":"Methods of isolation and purification of outer membrane vesicles from gram-negative bacteria","volume":"170","author":"Klimentova","year":"2015","journal-title":"Microbiol. Res."},{"key":"10.1016\/j.biotechadv.2017.05.003_bb0195","series-title":"A Multi-Serotype Outer Membrane Vesicles (MOMV) of Shigellae as a Novel Candidate Vaccine","author":"Koley","year":"2014"},{"issue":"17","key":"10.1016\/j.biotechadv.2017.05.003_bb0200","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/j.vaccine.2015.03.010","article-title":"Salmonella outer membrane vesicles displaying high densities of pneumococcal antigen at the surface offer protection against colonization","volume":"33","author":"Kuipers","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.biotechadv.2017.05.003_bb0205","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1146\/annurev.micro.091208.073413","article-title":"Biological functions and biogenesis of secreted bacterial outer membrane vesicles","volume":"64","author":"Kulp","year":"2010","journal-title":"Annu. Rev. Microbiol."},{"issue":"Part A","key":"10.1016\/j.biotechadv.2017.05.003_bb0210","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jconrel.2015.09.069","article-title":"Shape and size-dependent immune response to antigen-carrying nanoparticles","volume":"220","author":"Kumar","year":"2015","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.biotechadv.2017.05.003_bb0215","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.vaccine.2012.10.083","article-title":"Virus-like particles as a highly efficient vaccine platform: diversity of targets and production systems and advances in clinical development","volume":"31","author":"Kushnir","year":"2012","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.biotechadv.2017.05.003_bb0220","doi-asserted-by":"crossref","first-page":"3650","DOI":"10.1021\/acs.molpharmaceut.5b00364","article-title":"Exogenous DNA loading into extracellular vesicles via electroporation is size-dependent and enables limited gene delivery","volume":"12","author":"Lamichhane","year":"2015","journal-title":"Mol. Pharm."},{"issue":"19","key":"10.1016\/j.biotechadv.2017.05.003_bb0225","doi-asserted-by":"crossref","first-page":"4425","DOI":"10.1128\/JB.00625-13","article-title":"Comparative proteome analysis of spontaneous outer membrane vesicles and purified outer membranes of Neisseria meningitidis","volume":"195","author":"Lappann","year":"2013","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.biotechadv.2017.05.003_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2005.01.110","article-title":"Bacterial derived proteoliposome for allergy vaccines","volume":"24","author":"Lastre","year":"2006","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.biotechadv.2017.05.003_bb0235","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1128\/IAI.01382-12","article-title":"Lipopolysaccharide modifications of a cholera vaccine candidate based on outer membrane vesicles reduce endotoxicity and reveal the major protective antigen","volume":"81","author":"Leitner","year":"2013","journal-title":"Infect. Immun."},{"key":"10.1016\/j.biotechadv.2017.05.003_bb0240","doi-asserted-by":"crossref","first-page":"823","DOI":"10.3389\/fmicb.2015.00823","article-title":"A combined vaccine approach against Vibrio cholerae and ETEC based on outer membrane vesicles","volume":"6","author":"Leitner","year":"2015","journal-title":"Front. Microbiol."},{"issue":"10","key":"10.1016\/j.biotechadv.2017.05.003_bb0245","doi-asserted-by":"crossref","first-page":"5981","DOI":"10.1128\/IAI.69.10.5981-5990.2001","article-title":"Modification of lipid A biosynthesis in Neisseria meningitidis lpxL mutants: influence on lipopolysaccharide structure, toxicity, and adjuvant activity","volume":"69","author":"van der Ley","year":"2001","journal-title":"Infect. Immun."},{"key":"10.1016\/j.biotechadv.2017.05.003_bb0250","article-title":"Fusion protein for secretory protein expression","author":"Luirink","year":"2016","journal-title":"Abera Bioscience AB"},{"issue":"2","key":"10.1016\/j.biotechadv.2017.05.003_bb0255","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/ppsc.200601031","article-title":"Nano-particle tracking analysis \u2013 the halo\u2122 system","volume":"23","author":"Malloy","year":"2006","journal-title":"Part. Part. Syst. Charact."},{"issue":"5","key":"10.1016\/j.biotechadv.2017.05.003_bb0260","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/eji.200737984","article-title":"Nanoparticles target distinct dendritic cell populations according to their size","volume":"38","author":"Manolova","year":"2008","journal-title":"Eur. J. Immunol."},{"issue":"12","key":"10.1016\/j.biotechadv.2017.05.003_bb0265","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/j.vaccine.2013.01.021","article-title":"A phase 2 open-label safety and immunogenicity study of a meningococcal B bivalent rLP2086 vaccine in healthy adults","volume":"31","author":"Marshall","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.biotechadv.2017.05.003_bb0270","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/0076-6879(95)60143-0","article-title":"Purified and protein-loaded mitochondrial outer membrane vesicles for functional analysis of preprotein transport","volume":"260","author":"Mayer","year":"1995","journal-title":"Methods Enzymol."},{"issue":"2","key":"10.1016\/j.biotechadv.2017.05.003_bb0275","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1365-2958.2006.05522.x","article-title":"Release of outer membrane vesicles by gram-negative bacteria is a novel envelope stress response","volume":"63","author":"McBroom","year":"2007","journal-title":"Mol. Microbiol."},{"issue":"31","key":"10.1016\/j.biotechadv.2017.05.003_bb0280","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1016\/j.vaccine.2013.05.001","article-title":"Multi-serotype outer membrane vesicles of Shigellae confer passive protection to the neonatal mice against shigellosis","volume":"31","author":"Mitra","year":"2013","journal-title":"Vaccine"},{"issue":"13","key":"10.1016\/j.biotechadv.2017.05.003_bb0285","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/j.vaccine.2011.01.011","article-title":"Adjuvant system AS03 containing \u03b1-tocopherol modulates innate immune response and leads to improved adaptive immunity","volume":"29","author":"Morel","year":"2011","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.biotechadv.2017.05.003_bb0290","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1128\/IAI.00950-10","article-title":"Immunization with Salmonella enterica serovar typhimurium-derived outer membrane vesicles delivering the pneumococcal protein PspA confers protection against challenge with Streptococcus pneumoniae","volume":"79","author":"Muralinath","year":"2011","journal-title":"Infect. Immun."},{"issue":"11","key":"10.1016\/j.biotechadv.2017.05.003_bb0295","doi-asserted-by":"crossref","first-page":"6511","DOI":"10.1128\/IAI.72.11.6511-6518.2004","article-title":"Expression of heterologous antigens in commensal Neisseria spp.: preservation of conformational epitopes with vaccine potential","volume":"72","author":"O'Dwyer","year":"2004","journal-title":"Infect. Immun."},{"issue":"7","key":"10.1016\/j.biotechadv.2017.05.003_bb0300","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1128\/IAI.70.7.3621-3626.2002","article-title":"Neisseria lactamica protects against experimental meningococcal infection","volume":"70","author":"Oliver","year":"2002","journal-title":"Infect. Immun."},{"issue":"5","key":"10.1016\/j.biotechadv.2017.05.003_bb0305","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0097103","article-title":"Positional assembly of enzymes on bacterial outer membrane vesicles for cascade reactions","volume":"9","author":"Park","year":"2014","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.biotechadv.2017.05.003_bb0310","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/biot.201400395","article-title":"Outer membrane vesicles as platform vaccine technology","volume":"10","author":"van der Pol","year":"2015","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.biotechadv.2017.05.003_bb0315","doi-asserted-by":"crossref","first-page":"24931","DOI":"10.1038\/srep24931","article-title":"Glycoengineered outer membrane vesicles: a novel platform for bacterial vaccines","volume":"6","author":"Price","year":"2016","journal-title":"Sci. Report."},{"key":"10.1016\/j.biotechadv.2017.05.003_bb0320","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/3576028","article-title":"Comparison of intranasal outer membrane vesicles with cholera toxin and injected MF59C.1 as adjuvants for malaria transmission blocking antigens AnAPN1 and Pfs48\/45","author":"Pritsch","year":"2016","journal-title":"J Immunol Res"},{"issue":"10","key":"10.1016\/j.biotechadv.2017.05.003_bb0330","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.vaccine.2016.01.028","article-title":"Recombinant M2e outer membrane vesicle vaccines protect against lethal influenza A challenge in BALB\/c mice","volume":"34","author":"Rappazzo","year":"2016","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.biotechadv.2017.05.003_bb0335","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/nm1129","article-title":"From Pasteur to genomics: progress and challenges in infectious diseases","volume":"10","author":"Rappuoli","year":"2004","journal-title":"Nat. Med."},{"issue":"8","key":"10.1016\/j.biotechadv.2017.05.003_bb0340","doi-asserted-by":"crossref","first-page":"5162","DOI":"10.1128\/IAI.69.8.5162-5165.2001","article-title":"Localization of surface immunogenic protein on group B streptococcus","volume":"69","author":"Rioux","year":"2001","journal-title":"Infect. Immun."},{"issue":"8","key":"10.1016\/j.biotechadv.2017.05.003_bb0345","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/0dbc4010-f114-42fc-aafa-3efeef4d3068","article-title":"Intranasal immunization with nontypeable Haemophilus influenzae outer membrane vesicles induces cross-protective immunity in mice","volume":"7","author":"Roier","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.biotechadv.2017.05.003_bb0350","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s12026-013-8427-6","article-title":"Combined meningococcal serogroup A and W135 outer-membrane vesicles activate cell-mediated immunity and long-term memory responses against non-covalent capsular polysaccharide A","volume":"58","author":"Romeu","year":"2014","journal-title":"Immunol. Res."},{"key":"10.1016\/j.biotechadv.2017.05.003_bb0355","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3389\/fmicb.2014.00172","article-title":"Recombinant protein expression in Escherichia coli: advances and challenges","volume":"5","author":"Rosano","year":"2014","journal-title":"Front. Microbiol."},{"issue":"11","key":"10.1016\/j.biotechadv.2017.05.003_bb0360","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112802","article-title":"Mechanistic insight into the TH1-biased immune response to recombinant subunit vaccines delivered by probiotic bacteria-derived outer membrane vesicles","volume":"9","author":"Rosenthal","year":"2014","journal-title":"PLoS One"},{"issue":"46","key":"10.1016\/j.biotechadv.2017.05.003_bb0365","doi-asserted-by":"crossref","first-page":"5451","DOI":"10.1016\/j.vaccine.2013.08.099","article-title":"Meningococcal factor H-binding protein vaccines with decreased binding to human complement factor H have enhanced immunogenicity in human factor H transgenic mice","volume":"31","author":"Rossi","year":"2013","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.biotechadv.2017.05.003_bb0370","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.vaccine.2016.01.019","article-title":"Surface display of a borrelial lipoprotein on meningococcal outer membrane vesicles","volume":"34","author":"Salverda","year":"2016","journal-title":"Vaccine"},{"issue":"25\u201326","key":"10.1016\/j.biotechadv.2017.05.003_bb0375","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1016\/S0264-410X(01)00077-9","article-title":"Evaluation of cross-reactive antigens as determinants of cross-bactericidal activity in pathogenic and commensal Neisseria","volume":"19","author":"Sanchez","year":"2001","journal-title":"Vaccine"},{"issue":"Pt 12","key":"10.1016\/j.biotechadv.2017.05.003_bb0380","doi-asserted-by":"crossref","first-page":"3982","DOI":"10.1099\/mic.0.034991-0","article-title":"The Bam (Omp85) complex is involved in secretion of the autotransporter haemoglobin protease","volume":"155","author":"Sauri","year":"2009","journal-title":"Microbiology"},{"issue":"1","key":"10.1016\/j.biotechadv.2017.05.003_bb0385","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1128\/IAI.01139-08","article-title":"Characterization of Vibrio cholerae outer membrane vesicles as a candidate vaccine for cholera","volume":"77","author":"Schild","year":"2009","journal-title":"Infect. Immun."},{"issue":"48","key":"10.1016\/j.biotechadv.2017.05.003_bb0390","doi-asserted-by":"crossref","first-page":"6748","DOI":"10.1016\/j.vaccine.2009.08.106","article-title":"Recombinant outer membrane vesicles to augment antigen-specific live vaccine responses","volume":"27","author":"Schroeder","year":"2009","journal-title":"Vaccine"},{"issue":"18","key":"10.1016\/j.biotechadv.2017.05.003_bb0395","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1128\/JB.02192-12","article-title":"Synthetic effect between envelope stress and lack of outer membrane vesicle production in Escherichia Coli","volume":"195","author":"Schwechheimer","year":"2013","journal-title":"J. Bacteriol."},{"issue":"Suppl. 2","key":"10.1016\/j.biotechadv.2017.05.003_bb0400","doi-asserted-by":"crossref","first-page":"B87","DOI":"10.1016\/j.vaccine.2012.01.033","article-title":"The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: immunological, functional and structural characterization of the antigens","volume":"30","author":"Serruto","year":"2012","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.biotechadv.2017.05.003_bb0405","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1021\/bp0340640","article-title":"Cell surface display of organophosphorus hydrolase in Pseudomonas putida using an ice-nucleation protein anchor","volume":"19","author":"Shimazu","year":"2003","journal-title":"Biotechnol. Prog."},{"issue":"1","key":"10.1016\/j.biotechadv.2017.05.003_bb0410","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.phrp.2014.10.012","article-title":"Preparation and evaluation of a new lipopolysaccharide-based conjugate as a vaccine candidate for brucellosis","volume":"6","author":"Siadat","year":"2015","journal-title":"Osong Public Health and Research Perspectives"},{"issue":"2","key":"10.1016\/j.biotechadv.2017.05.003_bb0415","first-page":"195","article-title":"Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba","volume":"14","author":"Sierra","year":"1991","journal-title":"NIPH Ann."},{"issue":"5","key":"10.1016\/j.biotechadv.2017.05.003_bb0420","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1586\/14760584.6.5.797","article-title":"Nanoparticles and microparticles as vaccine-delivery systems","volume":"6","author":"Singh","year":"2007","journal-title":"Expert Review of Vaccines"},{"issue":"2","key":"10.1016\/j.biotechadv.2017.05.003_bb0425","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1172\/JCI118423","article-title":"A novel Escherichia coli lipid A mutant that produces an antiinflammatory lipopolysaccharide","volume":"97","author":"Somerville","year":"1996","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.biotechadv.2017.05.003_bb0430","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/cyto.a.10115","article-title":"Flow cytometer for measurement of the light scattering of viral and other submicroscopic particles","volume":"57","author":"Steen","year":"2004","journal-title":"Cytometry A"},{"issue":"51","key":"10.1016\/j.biotechadv.2017.05.003_bb0435","doi-asserted-by":"crossref","first-page":"6097","DOI":"10.1016\/j.vaccine.2013.09.044","article-title":"Preclinical immunogenicity and functional activity studies of an A+W meningococcal outer membrane vesicle (OMV) vaccine and comparisons with existing meningococcal conjugate- and polysaccharide vaccines","volume":"31","author":"Tunheim","year":"2013","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.biotechadv.2017.05.003_bb0440","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/hel.12196","article-title":"Increased outer membrane vesicle formation in a helicobacter pylori tolB mutant","volume":"20","author":"Turner","year":"2015","journal-title":"Helicobacter"},{"issue":"5","key":"10.1016\/j.biotechadv.2017.05.003_bb0445","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1021\/pr401227e","article-title":"Porphyromonas gingivalis outer membrane vesicles exclusively contain outer membrane and periplasmic proteins and carry a cargo enriched with virulence factors","volume":"13","author":"Veith","year":"2014","journal-title":"J. Proteome Res."},{"issue":"7","key":"10.1016\/j.biotechadv.2017.05.003_bb0450","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/nprot.2012.065","article-title":"Fluorescent labeling of nano-sized vesicles released by cells and subsequent quantitative and qualitative analysis by high-resolution flow cytometry","volume":"7","author":"van der Vlist","year":"2012","journal-title":"Nat. Protoc."},{"issue":"9","key":"10.1016\/j.biotechadv.2017.05.003_bb0455","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1021\/ac200195n","article-title":"Quantitative sizing of nano\/microparticles with a tunable elastomeric pore sensor","volume":"83","author":"Vogel","year":"2011","journal-title":"Anal. Chem."},{"issue":"30","key":"10.1016\/j.biotechadv.2017.05.003_bb0460","doi-asserted-by":"crossref","first-page":"4810","DOI":"10.1016\/j.vaccine.2010.04.082","article-title":"Improved OMV vaccine against Neisseria meningitidis using genetically engineered strains and a detergent-free purification process","volume":"28","author":"van de Waterbeemd","year":"2010","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.biotechadv.2017.05.003_bb0465","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.ymthe.2017.01.010","article-title":"Safe recombinant outer membrane vesicles that display M2e elicit heterologous influenza protection","volume":"25","author":"Watkins","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.biotechadv.2017.05.003_bb0470","series-title":"Antimicrobial Resistance: Global Report on Surveillance","author":"WHO","year":"2014"},{"issue":"1","key":"10.1016\/j.biotechadv.2017.05.003_bb0475","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ymeth.2006.05.016","article-title":"Pathogen recognition and development of particulate vaccines: does size matter?","volume":"40","author":"Xiang","year":"2006","journal-title":"Methods"},{"issue":"12","key":"10.1016\/j.biotechadv.2017.05.003_bb0480","doi-asserted-by":"crossref","first-page":"E690","DOI":"10.1073\/pnas.1115485109","article-title":"Peptide tag forming a rapid covalent bond to a protein, through engineering a bacterial adhesin","volume":"109","author":"Zakeri","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.biotechadv.2017.05.003_bb0485","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1586\/14760584.2015.1026808","article-title":"Biosynthetically engineered lipopolysaccharide as vaccine adjuvant","volume":"14","author":"Zariri","year":"2015","journal-title":"Expert Rev Vaccines"},{"issue":"47","key":"10.1016\/j.biotechadv.2017.05.003_bb0490","doi-asserted-by":"crossref","first-page":"5585","DOI":"10.1016\/j.vaccine.2013.07.069","article-title":"Expression of human CEACAM1 in transgenic mice limits the Opa-specific immune response against meningococcal outer membrane vesicles","volume":"31","author":"Zariri","year":"2013","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.biotechadv.2017.05.003_bb0495","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1128\/IAI.00635-16","article-title":"Meningococcal outer membrane vesicle composition-dependent activation of the innate immune response","volume":"Vol. 84","author":"Zariri","year":"2016","journal-title":"Infect. Immun."},{"key":"10.1016\/j.biotechadv.2017.05.003_bb0500","doi-asserted-by":"crossref","first-page":"36575","DOI":"10.1038\/srep36575","article-title":"Modulating endotoxin activity by combinatorial bioengineering of meningococcal lipopolysaccharide","volume":"6","author":"Zariri","year":"2016","journal-title":"Sci. Rep."},{"issue":"35","key":"10.1016\/j.biotechadv.2017.05.003_bb0505","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1016\/j.vaccine.2016.05.049","article-title":"Improving the immunogenicity of a trivalent Neisseria meningitidis native outer membrane vesicle vaccine by genetic modification","volume":"34","author":"Zhang","year":"2016","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.biotechadv.2017.05.003_bb0510","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.vaccine.2013.11.069","article-title":"Nanoparticle vaccines","volume":"32","author":"Zhao","year":"2014","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.biotechadv.2017.05.003_bb0515","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1093\/infdis\/137.6.728","article-title":"Safety and immunogenicity of a Neisseria meningitidis type 2 protein vaccine in animals and humans","volume":"137","author":"Zollinger","year":"1978","journal-title":"J Infect Dis"}],"container-title":["Biotechnology Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0734975017300551?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0734975017300551?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T00:18:37Z","timestamp":1719188317000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0734975017300551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":102,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S0734975017300551"],"URL":"https:\/\/doi.org\/10.1016\/j.biotechadv.2017.05.003","relation":{},"ISSN":["0734-9750"],"issn-type":[{"value":"0734-9750","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bioengineering bacterial outer membrane vesicles as vaccine platform","name":"articletitle","label":"Article Title"},{"value":"Biotechnology Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biotechadv.2017.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}